Wstęp
Ta strona zawiera kompleksową analizę znanej historii wykorzystywania informacji poufnych w firmie Dorothy E Puhy. Insiderzy to członkowie kadry kierowniczej, dyrektorzy lub znaczący inwestorzy w spółce. Dokonywanie transakcji w ich firmach w oparciu o określone, niepubliczne informacje jest nielegalne. Nie oznacza to, że dokonywanie jakichkolwiek transakcji we własnych firmach jest nielegalne. Muszą jednak zgłaszać wszystkie transakcje do SEC za pośrednictwem formularza 4. Pomimo tych ograniczeń badania akademickie sugerują, że insiderzy – ogólnie rzecz biorąc – mają tendencję do osiągania lepszych wyników na rynku w swoich własnych firmach.
Średnia rentowność handlu
Średnia rentowność handlu to średni zwrot ze wszystkich zakupów na otwartym rynku dokonanych przez osobę mającą dostęp do informacji poufnych w ciągu ostatnich trzech lat. Aby to obliczyć, badamy każdy nieplanowany zakup na otwartym rynku dokonany przez insidera, z wyłączeniem wszystkich transakcji oznaczonych jako część planu handlowego 10b5-1. Następnie obliczamy średnią wydajność tych transakcji w ciągu 3, 6 i 12 miesięcy, uśredniając każdy z tych okresów, aby wygenerować ostateczny wskaźnik wydajności dla każdej transakcji. Na koniec uśredniamy wszystkie wskaźniki wydajności, aby obliczyć wskaźnik wydajności dla insidera. Na tej liście znajdują się wyłącznie insiderzy, którzy dokonali co najmniej trzech transakcji w ciągu ostatnich dwóch lat.
Jeśli rentowność handlu insiderów jest oznaczona notką„nie dotyczy”, oznacza to, że insider albo nie dokonał żadnych zakupów na otwartym rynku w ciągu ostatnich trzech lat, albo transakcje, których dokonał, są zbyt nowe, aby obliczyć wiarygodny wskaźnik wydajności.
Częstotliwość aktualizacji: codziennie
Spółki posiadające zgłoszone stanowiska osób mających dostęp do poufnych informacji
Z dokumentów SEC wynika, że Dorothy E Puhy zgłosił udziały lub transakcje w następujących spółkach:
| Papier wartościowy | Nazwa | Najnowsze raporty dotyczące udziałów |
|---|---|---|
| US:MDXG / MiMedx Group, Inc. | Director | 57 597 |
| US:AZTA / Azenta, Inc. | Director | 3 604 |
| US:US003CVR0169 / CONTRA ABIOMED INC | Director | 0 |
| US:US27828Q4029 / EFR Float PERP | Director | 0 |
Jak interpretować wykresy
Poniższe wykresy przedstawiają notowania akcji papierów wartościowych po każdej niezaplanowanej transakcji na otwartym rynku dokonanej przez Dorothy E Puhy. Nieplanowane transakcje to transakcje, które nie zostały dokonane w ramach planu handlowego 10b5-1. Notowania akcji przedstawiono na wykresie jako skumulowaną procentową zmianę ceny akcji. Na przykład, jeśli 1 stycznia 2019 r. dokonano transakcji poufnej, wykres pokaże dzienną procentową zmianę papieru wartościowego do dnia dzisiejszego. Jeżeli cena akcji wzrosłaby w tym czasie z 10 do 15 dolarów, skumulowana procentowa zmiana ceny akcji wyniosłaby 50%. Zmiana ceny z 10$ na 20$ będzie wynosić 100%, a zmiana ceny z 10$ na 5$ będzie wynosić -50%.
Ostatecznie staramy się określić, jak blisko transakcje insiderów korelują z nadmiernymi zwrotami (dodatnimi lub ujemnymi) z ceny akcji, aby sprawdzić, czy insider dostosowuje swoje transakcje w taki sposób, aby czerpać korzyści z informacji poufnych. Rozważmy sytuację, w której zrobił to ktoś z wewnątrz. W tej sytuacji oczekiwalibyśmy albo (a) dodatnich zwrotów po zakupach, albo (b) ujemnych zwrotów po sprzedaży. W przypadku (a) wykres ZAKUPU pokazywałby serię krzywych nachylonych w górę, wskazujących dodatnie zwroty po każdej transakcji zakupu. W przypadku (b) wykres SPRZEDAŻ pokazywałby serię krzywych o nachyleniu w dół, wskazujących ujemne zwroty po każdej transakcji sprzedaży.
Samo to jednak nie wystarczy, aby wyciągnąć wnioski. Gdyby np. cena akcji spółki przez wiele lat rosła niecyklicznie, to spodziewalibyśmy się, że wszystkie wykresy po zakupie będą wykazywały tendencję wzrostową. Podobnie niecykliczne spadki na przestrzeni wielu lat spowodowałyby spadek linii na wykresie po transakcjach. Żaden z tych wykresów nie sugeruje wykorzystywania informacji poufnych.
Najsilniejszym wskaźnikiem byłaby sytuacja, gdy cena akcji miała charakter wyjątkowo cykliczny, a na wykresie KUPNO występowały zarówno pozytywne sygnały na wykresie KUPNA, jak i negatywne na wykresie SPRZEDAŻY. Sytuacja ta wysoce sugerowałaby osobę mającą dostęp do informacji poufnych, która wykorzystywała transakcje w celu uzyskania korzyści finansowej.
Zakupy insidera MDXG / MiMedx Group, Inc. – krótkoterminowa analiza zysków
W tej części analizujemy rentowność każdego nieplanowanego zakupu od poufnych informacji na otwartym rynku dokonanego w MDXG / MiMedx Group, Inc.. Analiza ta pomaga zrozumieć, czy insider konsekwentnie generuje nietypowe zyski i czy warto ją śledzić. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze zakupy na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do maks |
Cena maks |
Maks Zysk ($) |
Maksymalny zwrot (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Sprzedaż insidera MDXG / MiMedx Group, Inc. — analiza strat krótkoterminowych
W tej sekcji analizujemy możliwość uniknięcia krótkoterminowych strat w wyniku każdej nieplanowanej sprzedaży poufnych informacji na otwartym rynku dokonanej w MDXG / MiMedx Group, Inc.. Konsekwentny wzorzec unikania strat może sugerować, że przyszłe transakcje sprzedaży mogą przewidywać spadki cen. Analiza ta obejmuje okres jednego roku po każdej transakcji, a wyniki mają charakter teoretyczny .
Poniższa tabela przedstawia najnowsze sprzedaże na otwartym rynku, które nie były częścią planu handlu automatycznego.
| Data transakcji | Ticker | Insider | Zgłoszone Akcje |
Zgłoszona Cena |
Skorygowane Akcje |
Skorygowana Cena |
Podstawa kalkulacji kosztów | Dni do min |
Cena min |
Uniknięta maksymalna strata ($) |
Uniknięta Maksymalna strata (%) |
|---|---|---|---|---|---|---|---|
| Nie znane są żadne nieplanowane transakcje na otwarttm rynku dla tej kombinacji insidera i papieru wartościowego |
Cena skorygowana to cena skorygowana o podział. Akcje skorygowane to akcje skorygowane o podział.
Historia handlu insiderów
Ta tabela przedstawia pełną listę transakcji insiderów dokonanych przez firmę Dorothy E Puhy ujawnioną Komisji Papierów Wartościowych (SEC).
| Data pliku | Data trans | Formularz | Ticker | Bezpieczeństwo | Kod | Akcje | Pozostałe akcje | Zmiana procent |
Cena udziału |
Wartość trans |
Pozostała Wartość |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-23 |
|
4 | MDXG |
MIMEDX GROUP, INC.
Common Stock |
A - Award | 28 609 | 57 597 | 98,69 | 6,47 | 185 100 | 372 653 | |
| 2024-06-06 |
|
4 | MDXG |
MIMEDX GROUP, INC.
Common Stock |
A - Award | 28 988 | 28 988 | 7,26 | 210 453 | 210 453 | ||
| 2023-02-15 |
|
4 | AZTA |
Azenta, Inc.
Common |
A - Award | 3 604 | 3 604 | |||||
| 2022-12-27 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | -11 335 | 0 | -100,00 | ||||
| 2022-12-27 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | -3 255 | 0 | -100,00 | ||||
| 2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | -263 | 3 633 | -6,75 | 293,34 | -77 148 | 1 065 704 | |
| 2022-08-12 |
|
4 | NASD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 681 | 3 896 | 21,18 | ||||
| 2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | -279 | 3 215 | -7,99 | 319,88 | -89 247 | 1 028 414 | |
| 2021-08-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 625 | 3 494 | 21,78 | ||||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Phantom Stock |
D - Sale to Issuer | -3 252 | 0 | -100,00 | 73,00 | -237 396 | ||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | -5 737 | 0 | -100,00 | 36,29 | -208 196 | ||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | -7 451 | 0 | -100,00 | 36,24 | -270 024 | ||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Option (right to buy) |
D - Sale to Issuer | -5 680 | 0 | -100,00 | 44,77 | -254 311 | ||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Deferred Stock |
D - Sale to Issuer | -9 372 | 0 | -100,00 | 73,00 | -684 156 | ||
| 2021-03-03 |
|
4 | EV |
Mirror Merger Sub 2, LLC
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -23 981 | 0 | -100,00 | ||||
| 2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 3 252 | 0,53 | ||||
| 2021-02-16 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 50 | 9 372 | 0,54 | ||||
| 2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -201 | 2 869 | -6,55 | 353,07 | -70 967 | 1 012 958 |
| 2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 304 | 3 070 | -29,81 | 351,97 | -458 969 | 1 080 548 |
| 2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 649 | 4 374 | -27,38 | 351,34 | -579 360 | 1 536 761 |
| 2021-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 846 | 6 023 | -23,46 | 345,64 | -638 051 | 2 081 790 |
| 2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 193 | 3 235 | 6,34 | ||||
| 2020-12-18 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 557 | 9 322 | 6,35 | ||||
| 2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 19 | 3 042 | 0,63 | ||||
| 2020-11-17 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 40 | 8 765 | 0,46 | ||||
| 2020-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 2 317 | 8 725 | 36,16 | ||||
| 2020-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 661 | 7 869 | 9,17 | ||||
| 2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 30 | 3 023 | 1,00 | ||||
| 2020-08-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 63 | 6 408 | 0,99 | ||||
| 2020-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | -444 | 7 208 | -5,80 | 314,98 | -139 851 | 2 270 376 | |
| 2020-07-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -7 500 | 7 652 | -49,50 | 275,00 | -2 062 500 | 2 104 300 |
| 2020-06-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -7 500 | 15 152 | -33,11 | 250,00 | -1 875 000 | 3 788 000 |
| 2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 34 | 2 993 | 1,15 | ||||
| 2020-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 72 | 6 345 | 1,15 | ||||
| 2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 959 | 0,82 | ||||
| 2020-02-14 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 51 | 6 273 | 0,82 | ||||
| 2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 26 | 2 935 | 0,89 | ||||
| 2019-11-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 28 | 6 222 | 0,45 | ||||
| 2019-11-04 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 034 | 6 194 | 96,01 | ||||
| 2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 24 | 2 909 | 0,83 | ||||
| 2019-08-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 26 | 3 160 | 0,83 | ||||
| 2019-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | -224 | 22 652 | -0,98 | 189,93 | -42 544 | 4 302 294 | |
| 2019-08-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 053 | 22 876 | 4,83 | ||||
| 2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 25 | 2 885 | 0,87 | ||||
| 2019-05-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 27 | 3 134 | 0,87 | ||||
| 2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 27 | 2 860 | 0,95 | ||||
| 2019-02-15 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 30 | 3 107 | 0,97 | ||||
| 2018-11-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 22 | 2 833 | 0,78 | ||||
| 2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -2 112 | 0 | -100,00 | ||||
| 2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 112 | 0,76 | ||||
| 2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Deferred Stock |
A - Award | 3 077 | 3 077 | |||||
| 2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -2 112 | 23 981 | -8,09 | 45,50 | -96 096 | 1 091 136 | |
| 2018-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 112 | 26 093 | 8,81 | ||||
| 2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 096 | 0,58 | ||||
| 2018-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 17 | 2 811 | 0,61 | ||||
| 2018-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
F - Taxes | -541 | 21 823 | -2,42 | 376,01 | -203 421 | 8 205 666 | |
| 2018-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 531 | 22 364 | 2,43 | ||||
| 2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 084 | 0,58 | ||||
| 2018-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 794 | 0,58 | ||||
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | -13 500 | 0 | -100,00 | |||
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -300 | 33 168 | -0,90 | 351,97 | -105 591 | 11 674 141 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -900 | 33 468 | -2,62 | 351,06 | -315 953 | 11 749 239 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -700 | 34 368 | -2,00 | 349,98 | -244 986 | 12 028 113 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -4 195 | 35 068 | -10,68 | 349,07 | -1 464 351 | 12 241 208 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 500 | 39 263 | -3,68 | 348,07 | -522 108 | 13 666 351 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -3 012 | 40 763 | -6,88 | 347,07 | -1 045 367 | 14 147 513 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 664 | 43 775 | -3,66 | 346,20 | -576 077 | 15 154 905 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 229 | 45 439 | -2,63 | 345,10 | -424 132 | 15 681 162 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 46 668 | 40,70 | 9,99 | 134 865 | 466 213 |
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | 11 335 | 11 335 | |||||
| 2018-05-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
G - Gift | -11 335 | 21 833 | -34,17 | ||||
| 2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 072 | 0,53 | ||||
| 2018-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 778 | 0,54 | ||||
| 2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -11 777 | 0 | -100,00 | ||||
| 2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -4 045 | 0 | -100,00 | ||||
| 2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -9 490 | 23 981 | -28,35 | 60,49 | -574 050 | 1 450 611 | |
| 2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 045 | 33 471 | 13,75 | 41,90 | 169 486 | 1 402 435 | |
| 2018-01-17 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 11 777 | 29 426 | 66,73 | 34,84 | 410 311 | 1 025 202 | |
| 2017-11-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 061 | 0,63 | ||||
| 2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -1 587 | 0 | -100,00 | ||||
| 2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 587 | 0,63 | ||||
| 2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -1 587 | 17 649 | -8,25 | 51,04 | -81 000 | 900 805 | |
| 2017-11-06 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 587 | 19 236 | 8,99 | ||||
| 2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 381 | 1 381 | |||||
| 2017-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 808 | 6 808 | |||||
| 2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | -13 500 | 0 | -100,00 | |||
| 2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -2 700 | 33 168 | -7,53 | 179,49 | -484 613 | 5 953 205 |
| 2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -3 664 | 35 868 | -9,27 | 178,77 | -655 024 | 6 412 230 |
| 2017-11-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 39 532 | 51,86 | 7,67 | 103 545 | 303 210 |
| 2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -6 420 | 0 | -100,00 | ||||
| 2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -4 902 | 0 | -100,00 | ||||
| 2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -5 953 | 17 649 | -25,22 | 51,08 | -304 105 | 901 587 | |
| 2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 902 | 23 602 | 26,21 | 28,68 | 140 614 | 677 023 | |
| 2017-10-27 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 420 | 18 700 | 52,28 | 24,46 | 157 030 | 457 393 | |
| 2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -6 865 | 0 | -100,00 | ||||
| 2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -6 495 | 12 280 | -34,59 | 49,38 | -320 696 | 606 335 | |
| 2017-10-02 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 6 865 | 18 775 | 57,64 | 47,23 | 324 237 | 886 753 | |
| 2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 577 | 0,64 | ||||
| 2017-08-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 048 | 0,59 | ||||
| 2017-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 283 | 26 032 | 5,18 | ||||
| 2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -4 883 | 0 | -100,00 | ||||
| 2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -2 563 | 11 910 | -17,71 | 48,46 | -124 195 | 577 120 | |
| 2017-06-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 4 883 | 14 473 | 50,92 | 27,50 | 134 258 | 397 935 | |
| 2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 567 | 0,71 | ||||
| 2017-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 036 | 0,69 | ||||
| 2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | -13 500 | 0 | -100,00 | |||
| 2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 111 | 24 749 | -4,30 | 132,50 | -147 211 | 3 279 322 |
| 2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -5 758 | 25 860 | -18,21 | 131,42 | -756 709 | 3 398 488 |
| 2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -6 631 | 31 618 | -17,34 | 130,63 | -866 236 | 4 130 395 |
| 2017-05-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 13 500 | 38 249 | 54,55 | 18,63 | 251 505 | 712 579 |
| 2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 556 | 0,65 | ||||
| 2017-02-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 022 | 0,65 | ||||
| 2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Stock option (right to buy) |
M - Exercise | X | -8 000 | 0 | -100,00 | |||
| 2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -8 000 | 24 749 | -24,43 | 120,00 | -960 000 | 2 969 880 |
| 2016-12-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 8 000 | 32 749 | 32,32 | 12,69 | 101 520 | 415 585 |
| 2016-11-17 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 546 | 0,78 | ||||
| 2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -1 448 | 0 | -100,00 | ||||
| 2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 448 | 0,77 | ||||
| 2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -1 448 | 9 590 | -13,12 | 34,99 | -50 666 | 335 554 | |
| 2016-11-07 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 448 | 11 038 | 15,10 | ||||
| 2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 2 009 | 2 009 | |||||
| 2016-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 11 777 | 11 777 | |||||
| 2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -8 197 | 0 | -100,00 | ||||
| 2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -6 197 | 9 590 | -39,25 | 38,75 | -240 123 | 371 596 | |
| 2016-09-21 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 8 197 | 15 787 | 108,00 | 29,39 | 240 898 | 463 956 | |
| 2016-08-17 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -5 160 | 24 749 | -17,25 | 123,94 | -639 540 | 3 067 436 |
| 2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
| 2016-08-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 437 | 0,77 | ||||
| 2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -300 | 29 911 | -0,99 | 123,70 | -37 110 | 3 699 991 |
| 2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -600 | 30 211 | -1,95 | 122,99 | -73 792 | 3 715 551 |
| 2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -3 000 | 30 811 | -8,87 | 122,03 | -366 094 | 3 759 906 |
| 2016-08-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 621 | 33 811 | 5,04 | ||||
| 2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 426 | 0,78 | ||||
| 2016-05-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 1 523 | 0,79 | ||||
| 2016-04-20 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -10 000 | 32 190 | -23,70 | 100,00 | -1 000 000 | 3 219 000 |
| 2016-04-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -5 602 | 42 190 | -11,72 | 95,02 | -532 320 | 4 009 029 |
| 2016-04-01 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -4 398 | 47 792 | -8,43 | 95,01 | -417 874 | 4 540 933 |
| 2016-03-23 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -10 000 | 52 190 | -16,08 | 90,30 | -903 035 | 4 712 940 |
| 2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | -4 000 | 0 | -100,00 | |||
| 2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -4 000 | 62 190 | -6,04 | 85,00 | -340 000 | 5 286 150 |
| 2016-03-09 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | X | 4 000 | 66 190 | 6,43 | 13,21 | 52 840 | 874 370 |
| 2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -5 840 | 0 | -100,00 | ||||
| 2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
S - Sale | -2 500 | 7 590 | -24,78 | 30,18 | -75 450 | 229 067 | |
| 2016-03-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 840 | 10 090 | 137,41 | 27,32 | 159 545 | 275 652 | |
| 2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 415 | 1,00 | ||||
| 2016-02-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 1 511 | 1,00 | ||||
| 2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | X | -4 000 | 4 000 | -50,00 | |||
| 2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -4 000 | 62 190 | -6,04 | 80,47 | -321 898 | 5 004 709 |
| 2016-02-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 4 000 | 66 190 | 6,43 | 13,21 | 52 840 | 874 370 | |
| 2015-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 401 | 0,79 | ||||
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 496 | 1 496 | |||||
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 7 451 | 7 451 | |||||
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -1 259 | 0 | -100,00 | ||||
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 259 | 0,80 | ||||
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -1 259 | 4 250 | -22,85 | 36,11 | -45 462 | 153 468 | |
| 2015-11-03 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 259 | 5 509 | 29,62 | ||||
| 2015-08-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -2 580 | 62 190 | -3,98 | 103,91 | -268 088 | 6 462 163 |
| 2015-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -2 580 | 64 770 | -3,83 | 105,27 | -271 597 | 6 818 338 |
| 2015-08-14 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 3 900 | 67 350 | 6,15 | ||||
| 2015-08-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 778 | 63 450 | -2,73 | 97,69 | -173 693 | 6 198 430 |
| 2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 390 | 0,72 | ||||
| 2015-08-12 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 249 | 0,73 | ||||
| 2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 380 | 0,66 | ||||
| 2015-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 240 | 0,65 | ||||
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -19 | 65 228 | -0,03 | 69,81 | -1 326 | 4 553 560 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -174 | 65 247 | -0,27 | 69,03 | -12 011 | 4 504 040 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -737 | 65 421 | -1,11 | 67,88 | -50 026 | 4 440 620 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -1 301 | 66 158 | -1,93 | 67,33 | -87 601 | 4 454 656 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -510 | 67 459 | -0,75 | 66,33 | -33 829 | 4 474 582 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -971 | 67 969 | -1,41 | 65,13 | -63 240 | 4 426 760 |
| 2015-05-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -864 | 68 940 | -1,24 | 64,16 | -55 434 | 4 423 177 |
| 2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -22 | 69 804 | -0,03 | 73,78 | -1 623 | 5 149 881 |
| 2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -128 | 69 826 | -0,18 | 73,00 | -9 344 | 5 097 500 |
| 2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -260 | 69 954 | -0,37 | 71,85 | -18 681 | 5 026 307 |
| 2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -403 | 70 214 | -0,57 | 70,81 | -28 536 | 4 971 790 |
| 2015-05-11 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | X | -2 611 | 70 617 | -3,57 | 70,00 | -182 762 | 4 942 985 |
| 2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 371 | 0,66 | ||||
| 2015-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 232 | 0,65 | ||||
| 2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | -8 000 | 0 | -100,00 | ||||
| 2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | -1 572 | 73 228 | -2,10 | 51,93 | -81 634 | 3 802 730 | |
| 2015-02-03 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 74 800 | 11,98 | 10,06 | 80 480 | 752 488 | |
| 2014-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 224 | 0,74 | ||||
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 362 | 1 362 | |||||
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 737 | 5 737 | |||||
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -1 870 | 0 | -100,00 | ||||
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 870 | 0,75 | ||||
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -1 870 | 4 250 | -30,56 | 36,83 | -68 872 | 156 528 | |
| 2014-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 1 870 | 6 120 | 44,00 | ||||
| 2014-08-29 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
D - Sale to Issuer | -3 000 | 66 800 | -4,30 | 25,70 | -77 104 | 1 716 854 | |
| 2014-08-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 69 800 | 12,47 | ||||
| 2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 215 | 0,58 | ||||
| 2014-08-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 856 | 0,60 | ||||
| 2014-06-13 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | -8 000 | 0 | -100,00 | ||||
| 2014-06-13 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 62 060 | 14,80 | 10,41 | 83 280 | 646 045 | |
| 2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 8 | 1 208 | 0,67 | ||||
| 2014-05-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 845 | 0,60 | ||||
| 2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 7 | 1 200 | 0,59 | ||||
| 2014-02-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 10 | 1 834 | 0,55 | ||||
| 2013-11-13 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 824 | 0,61 | ||||
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 193 | 1 193 | |||||
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -2 167 | 0 | -100,00 | ||||
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 12 | 2 167 | 0,56 | ||||
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 045 | 4 045 | |||||
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -2 167 | 4 250 | -33,77 | 41,90 | -90 797 | 178 075 | |
| 2013-11-05 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 2 167 | 6 417 | 50,99 | ||||
| 2013-08-16 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 7 740 | 54 060 | 16,71 | ||||
| 2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 813 | 0,50 | ||||
| 2013-08-09 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 155 | 0,51 | ||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 9 | 1 804 | 0,50 | ||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 2 144 | 0,52 | ||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 883 | 4 883 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 680 | 5 680 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 420 | 6 420 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 4 902 | 4 902 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 6 865 | 6 865 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 8 197 | 8 197 | |||||
| 2013-05-16 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 840 | 5 840 | |||||
| 2013-02-12 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | 7 000 | 0 | -100,00 | 5,40 | 37 800 | ||
| 2013-02-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 7 000 | 46 320 | 17,80 | 5,40 | 37 800 | 250 128 | |
| 2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 11 | 1 795 | 0,62 | ||||
| 2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 55 | 1 784 | 3,18 | ||||
| 2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 2 133 | 0,61 | ||||
| 2012-12-26 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 65 | 2 120 | 3,16 | ||||
| 2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
M - Exercise | -5 800 | 0 | -100,00 | ||||
| 2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
D - Sale to Issuer | -4 050 | 4 250 | -48,80 | 31,77 | -128 675 | 135 029 | |
| 2012-12-12 |
|
4 | EV |
EATON VANCE CORP
Eaton Vance Corp. Non-voting Common Stock |
M - Exercise | 5 800 | 8 300 | 232,00 | 21,99 | 127 542 | 182 517 | |
| 2012-11-14 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 2 055 | 0,69 | ||||
| 2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 1 729 | 1 729 | |||||
| 2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
M - Exercise | -1 799 | 0 | -100,00 | ||||
| 2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 799 | 0,73 | ||||
| 2012-11-02 |
|
4 | EV |
EATON VANCE CORP
Option (right to buy) |
A - Award | 5 543 | 5 543 | 28,92 | 160 304 | 160 304 | ||
| 2012-08-10 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 39 320 | 15,69 | ||||
| 2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 041 | 0,74 | ||||
| 2012-08-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 786 | 0,73 | ||||
| 2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 15 | 2 026 | 0,75 | ||||
| 2012-05-15 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 13 | 1 773 | 0,74 | ||||
| 2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 16 | 2 011 | 0,80 | ||||
| 2012-02-10 |
|
4 | EV |
EATON VANCE CORP
Phantom Stock |
A - Award | 14 | 1 760 | 0,80 | ||||
| 2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | 8 000 | 7 000 | -800,00 | 5,40 | 43 200 | 37 800 | |
| 2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
S - Sale | -4 000 | 33 987 | -10,53 | 23,11 | -92 440 | 785 443 | |
| 2012-02-08 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 8 000 | 37 987 | 26,68 | 5,40 | 43 200 | 205 130 | |
| 2011-08-12 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 5 333 | 29 987 | 21,63 | ||||
| 2011-05-23 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | -5 000 | 15 000 | -25,00 | ||||
| 2011-05-23 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 27 654 | 22,07 | 5,40 | 27 000 | 149 332 | |
| 2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | -5 000 | 20 000 | -20,00 | ||||
| 2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 22 654 | 28,32 | 5,40 | 27 000 | 122 332 | |
| 2010-11-19 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 13 500 | 13 500 | |||||
| 2010-08-13 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 13 500 | 13 500 | |||||
| 2010-04-15 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 453 | 17 654 | 8,97 | 10,32 | 14 995 | 182 189 | |
| 2009-08-14 |
|
4 | ABMD |
ABIOMED INC
Stock Options (right to buy) |
A - Award | 13 500 | 13 500 | 7,67 | 103 545 | 103 545 | ||
| 2008-08-15 |
|
4 | ABMD |
ABIOMED INC
Stock Options (right to buy) |
A - Award | 13 500 | 13 500 | 18,63 | 251 505 | 251 505 | ||
| 2008-04-02 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 141 | 11 500 | 11,01 | 13,14 | 14 993 | 151 110 | |
| 2008-02-28 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
M - Exercise | -5 000 | 0 | -100,00 | ||||
| 2008-02-28 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
M - Exercise | 5 000 | 10 359 | 93,30 | 5,15 | 25 750 | 53 349 | |
| 2007-08-10 |
|
4 | ABMD |
ABIOMED INC
Stock option (right to buy) |
A - Award | 8 000 | 8 000 | 12,69 | 101 520 | 101 520 | ||
| 2007-05-18 |
|
4 | ABMD |
ABIOMED INC
Common Stock, $0.01 par value |
A - Award | 1 254 | 5 359 | 30,55 | 11,96 | 14 998 | 64 094 | |
| 2006-08-10 |
|
4 | ABMD |
ABIOMED INC
Stock Option (right to buy) |
A - Award | 8 000 | 8 000 | 13,21 | 105 680 | 105 680 |
